Medullary thyroid carcinoma experienced at Kanazawa University Hospital

Journal of Surgical Oncology

Volumn 61, Issue 1, 1996, Pages 27-33

  Mizukami, Yuji ^a   Nonomura, Akitaka ^a   Michigishi, Takatoshi ^a   Noguchi, Masakuni ^a   Ohtake, Shinobu ^a   Nakamura, Shinobu ^a   Ishizaki, Takeshi ^b  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

histology; immunohistochemistry; medullary thyroid carcinoma; prognosis

Indexed keywords

CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; PROGNOSIS; THYROID MEDULLARY CARCINOMA;

ADULT; AGED; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 0030064785     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199601)61:1<27::AID-JSO7>3.0.CO;2-U     Document Type: Article

References (40)

1. LiVolsi VA (ed): "Surgical Pathology of the Thyroid." Philadelphia: W.B. Saunders, 1990.
2. Ljungberg O (ed): "Biopsy Pathology of the Thyroid and Parathyroid." London: Chapman & Hall, 1992.
3. Ezaki H, Ebihara S, Fujimoto Y, et al: Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special reference to predominance of papillary type. Cancer 70:808-814, 1992.
4. Koike A, Naruse T: Incidence of thyroid cancer in Japan. Semin Surg Oncol 7:107-111, 1991.
5. Bergholm U, Adami HO, Auer G, et al.: Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma. A nationwide study in Sweden. Cancer 64:135-142, 1989.
6. Hay ID, Ryan JJ, Grant CS, et al.: Prognostic significance of nondiploid DNA determination by flow cytometry in sporadic and familial medullary thyroid carcinoma. Surgery 108:972-980, 1990.
7. Kallinowski F, Buhr HJ, Meybier H, et al.: Medullary carcinoma of the thyroid - Therapeutic strategy derived from fifteen years of experience. Surgery 114:491-496, 1993.
8. Saad MF, Ordonez NG, Guido JJ, Samaan NA: The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid. J Clin Endocrinol Metab 59:850-856, 1984.
9. Schroder S, Bocker W, Baisch H, et al.: Prognostic factors in medullary thyroid carcinomas: Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 61:806-816, 1988.
10. El-Naggar AK, Ordonez NG, McLemore D, et al.: Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma. Surgery 108:981-985, 1990.
11. Galera-Davidson H, Gonzalez-Campora R, Mora-Marin JA, et al: Cytophotometric DNA measurements in medullary thyroid carcinoma. Cancer 65:2255-2260, 1990.
12. Mendelsohn G, Wells SA, Baylin SB: Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease. Cancer 54:657-662, 1984.
13. Pacini F, Basolo F, Elisei R, et al.: Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. Am J Clin Pathol 95:300-308, 1991.
14. Takami H, Bessho T, Kameya T, et al.: Immunohistochemical study of medullary thyroid carcinoma: Relationship of clinical features to prognostic factors in 36 patients. World J Surg 12:572-579, 1988.
15. Hedinger C, Williams ED, Sobin LH (eds): "International Histological Classification of Tumors, 2nd ed." Berlin: Springer-Verlag, 1988.
16. Rosai J, Carcangiu ML, DeLellis RA (eds): "Tumors of the Thyroid Gland. Atlas of Tumor Pathology, 3rd Series Fascicle 5." Washington, DC: Armed Forces Institute of Pathology, 1992.
17. Mizukami Y, Kurumaya H, Nonomura A, et al.: Sporadic medullary microcarcinoma of the thyroid. Histopathology 21:375-377, 1992.
18. Mizukami Y, Michigishi T, Nonomura A, et al.: Mixed medullary-follicular carcinoma of the thyroid occurring in familial form. Histopathology 22:284-287, 1993.
19. Goodman MT, Yoshizawa CN, Kolonel LN: Descriptive epidemiology of thyroid cancer in Hawaii. Cancer 62:1272-1281, 1988.
20. Spitz MR, Soder JG, Katz RL, et al.: Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. Int J Cancer 42:549-553, 1988.
21. Gagel RF, Robinson MF, Donovan DT, Alford BR: Medullary thyroid carcinoma: Recent progress. J Clin Endocrinol Metab 76:809-814, 1993
22. de Bustros AC, Baylin SB: Medullary carcinoma of the thyroid. In Braverman LE, Utiger RD (eds): "The Thyroid, 6th ed." Philadelphia: Lippincott Co, 1991, p 1166-1183.
23. Decker RA: Long-term follow-up of a large North American kindred with multiple endocrine neoplasia type 2A. Surgery 112:1066-1073, 1992.
24. Duh QY, Sancho JJ, Greenspan FS, et al.: Medullary thyroid carcinoma: The need for early diagnosis and total thyroidectomy. Arch Surg 124:1206-1210, 1989.
25. Farndon JR, Leight GS, Dilley WG, et al.: Familial medullary thyroid carcinoma without associated endocrinopathies A distinct clinical entity. Br j Surg 73:278-281, 1986.
26. Saad MF, Ordonez NG, Rashid RK, et al.: Medullary carcinoma of the thyroid: A study of the clinical features and prognostic factors in 161 patients. Medicine 63:319-342, 1984.
27. Vasen HFA, van der Feltz M, Raue F, et al. The natural course of multiple endocrine neoplasia type IIb: A study of 18 cases. Arch Intern Med 152:1250-1252, 1992.
28. Harach HR, Bergholm U: Fatal sporadic medullary carcinoma of the thyroid. Endocrinol Pathol 4:53-59, 1993.
29. Sambade C, Baldaque-Faria A, Cardoso-Oliveira M, Sobrinho-Simoes M: Follicular and papillary variants of medullary carcinoma of the thyroid. Pathol Res Pract 184:98-103, 1989.
30. Harach HR, Bergholm U: Medullary (C cell) carcinoma of the thyroid with features of follicular oxyphilic cell rumors. Histopathology 13:645-656, 1988.
31. Lertprasertsuke N, Kakudo K, Nakamura A, et al.: C cell carcinoma of the thyroid: Follicular variant. Acta Pathol Jpn 39:393-399, 1989.
32. Dominguez-Malagon H, Delgado-Chavez R, Torres-Najera M, et al.: Oxyphil and squamous variants of medullary thyroid carcinoma. Cancer 63:1183-1188, 1989.
33. Kakudo K, Miyauchi A, Katayama S, Watanabe K: Ultrastructural study of poorly differentiated medullary carcinoma of the thyroid. Virchows Arch A Pathol Anat Histopathol 410:455-460, 1987.
34. Martinelli G, Bazzocchi F, Govoni E, Santini D: Anaplastic type of medullary thyroid carcinoma: an ultrastructural and immunohistochemical study. Virchows Arch [A] 400:61-67, 1983
35. Mendelsohn G, Baylin SB, Bigner SH, et al.: Anaplastic variants of medullary thyroid carcinoma: A light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333-341, 1980.
36. Eusebi V, Damiani SD, Riva C, et al.: Calcitonin free oat-cell carcinoma of the thyroid gland. Virchows Arch [A] 417:267-271, 1990.
37. Harach HR, Bergholm U: Small cell variant of medullary carcinoma of the thyroid with neuroblastoma-like features. Histopathology 21:378-380, 1992.
38. Pyke CM, Hay ID, Goellner JR, et al.: Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma. Surgery 110:964-971, 1991.
39. Mizukami Y, Noguchi M, Michigishi T, et al.: Papillary thyroid carcinoma in Kanazawa, Japan: Prognostic significance of histological subtypes. Histopathology 20:243-250, 1992.
40. Mizukami Y, Michigishi T, Nonomura A, et al.: Thyroid carcinoma: Clinical, pathologic correlations. Crit Rev Oncol Hematol 18:67-102, 1995.